Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That’s a compound annual growth rate ...

Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Merck & Co., Inc. (NYSE:MRK) is one of the Best Forever Stocks to Invest In Now. On October 10, Tim Anderson of Bank of ...

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House ...

Merck KGaA, a German integrated science, pharmaceutical, and technology company with a significant market presence in the U.S ...

The Trump administration struck a deal with EMD Serono, the health care business of Merck KGaA in the United States and ...

The massive AI deals and capital spending plans announced by some of the top technology companies have stunned many on Wall ...

Johnson & Johnson ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.

Weight-loss drug makers Novo Nordisk and Eli Lilly saw their stocks drop Friday after President Donald Trump vowed to lower the price of Novo's popular Ozempic treatment. At such a critical moment in ...